top of page
gradientForSurfBreak.png

Item List

Jun 17, 2025
Morningstar
Materna Medical Announces Ellora™ and Additional Close on $20M Series B2

Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of a recent close within an ongoing $20 million Series B2 financing round. The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors Wavemaker Three-Sixty Health, Kimera Limited, Women's Venture Capital Fund, and Golden Seeds.

Recent Posts

Portfolio Company

Carlsmed.png

Carlsmed Q2 Earnings Call Highlights
...

Yahoo Finance

Aug 5, 2026

Portfolio Company

Carlsmed.png

Epitel Secures $26 Million Series B to Expand Remote Wireless EEG Monitoring
...

Yahoo Finance

Jul 28, 2026

Portfolio Company

Carlsmed.png

Tombot Closes $7 Million Series A3 Growth Financing to Scale Operations and Expa ...

Businesswire

Jun 25, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page